5 Best Dialysis and Kidney Disease Stocks to Buy

Page 5 of 5

1. Thermo Fisher Scientific Inc. (NYSE:TMO)

Number of Hedge Fund Holders In Q2 2023: 103

Market Capitalization: $189 Billion

Thermo Fisher Scientific Inc. (NYSE:TMO) is a Waltham, Massachusetts-based life solutions firm that was incorporated in 1956. With a market capitalization of $189 billion, it tops our list of the best dialysis and kidney disease stocks to buy. Thermo Fisher Scientific Inc. (NYSE:TMO) offers dialysis treatment plans with 10 μL to 250 mL sample volumes. These devices do not require knots or clips and hence they reduce leaking and loss of sample.

It also agreed to acquire Olink Holding AB (publ) (NASDAQ:OLK) for $26 per American Depositary Share in cash to enhance its service offering. Thermo Fisher Scientific Inc. (NYSE:TMO) posted Q2 EPS of $5.51 beating analysts’ expectations of $5.42. Revenue for the quarter was $10.7 billion.

103 out of the 910 hedge funds surveyed by Insider Monkey had bought the firm’s shares in Q2 2023. Out of these, the firm’s largest investor is Chris Hohn’s TCI Fund Management since it owns 3.2 million shares that are worth $1.7 billion.

Disclosure: None. You can also take a look at 15 Best Healthcare Stocks To Buy Now and 10 Oversold Healthcare Stocks to Buy.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Follow Insider Monkey on Twitter

Page 5 of 5